Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations

被引:237
|
作者
Aanouz, I. [1 ]
Belhassan, A. [1 ]
El-Khatabi, K. [1 ]
Lakhlifi, T. [1 ]
El-Idrissi, M. [1 ]
Bouachrine, M. [1 ,2 ]
机构
[1] Moulay Ismail Univ Meknes, Mol Chem & Nat Subst Lab, Fac Sci, Meknes, Morocco
[2] Sultan Moulay Sliman Univ, EST Khenifra, Khenifra, Morocco
来源
关键词
Molecular docking; CoV-2019; natural herbal; crocin; digitoxigenin; beta-eudesmol; ACUTE RESPIRATORY SYNDROME; DOCKING;
D O I
10.1080/07391102.2020.1758790
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The new Corona-virus, recently called the severe acute respiratory syndrome Coronavirus (SARS-CoV-2) appears for the first time in China and more precisely in Wuhan (December 2019). This disease can be fatal. Seniors, and people with other medical conditions (diabetes, heart disease horizontal ellipsis ), may be more vulnerable and become seriously ill. This is why research into drugs to treat this infection remains essential in several research laboratories. Natural herbal remedies have long been the main, if not the only, remedy in the oral tradition for treating illnesses. Modern medicine has known its success thanks to traditional medicine, the effectiveness of which derives from medicinal plants. The objective of this study is to determine if the components of natural origin have an anti-viral effect and which can prevent humans from infection by this coronavirus using the most reliable method is molecular docking, which used to find the interaction between studied molecules and the protein, in our case we based on the inhibitor of Coronavirus (nCoV-2019) main protease. The results of molecular docking showed that among 67 molecules of natural origin, three molecules (Crocin, Digitoxigenin, and beta-Eudesmol) are proposed as inhibitors against the coronavirus based on the energy types of interaction between these molecules and studied protein. [GRAPHICS] .
引用
收藏
页码:2971 / 2979
页数:9
相关论文
共 50 条
  • [1] Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
    Somboon, Tuanjai
    Mahalapbutr, Panupong
    Sanachai, Kamonpan
    Maitarad, Phornphimon
    Lee, Vannajan Sanghiran
    Hannongbua, Supot
    Rungrotmongkol, Thanyada
    JOURNAL OF MOLECULAR LIQUIDS, 2021, 322
  • [2] Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2
    Medrano, Francisco J.
    de la Hoz-Rodriguez, Sergio
    Marti, Sergio
    Arafet, Kemel
    Schirmeister, Tanja
    Hammerschmidt, Stefan J.
    Mueller, Christin
    Gonzalez-Martinez, Agueda
    Santillana, Elena
    Ziebuhr, John
    Romero, Antonio
    Zimmer, Collin
    Weldert, Annabelle
    Zimmermann, Robert
    Lodola, Alessio
    Swiderek, Katarzyna
    Moliner, Vicent
    Gonzalez, Florenci V.
    COMMUNICATIONS CHEMISTRY, 2024, 7 (01)
  • [3] Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2
    Francisco J. Medrano
    Sergio de la Hoz-Rodríguez
    Sergio Martí
    Kemel Arafet
    Tanja Schirmeister
    Stefan J. Hammerschmidt
    Christin Müller
    Águeda González-Martínez
    Elena Santillana
    John Ziebuhr
    Antonio Romero
    Collin Zimmer
    Annabelle Weldert
    Robert Zimmermann
    Alessio Lodola
    Katarzyna Świderek
    Vicent Moliner
    Florenci V. González
    Communications Chemistry, 7
  • [4] Computational Repurposing of Potential Dimerization Inhibitors against SARS-CoV-2 Main Protease
    Borkotoky, Subhomoi
    Prakash, Archisha
    Modi, Gyan Prakash
    Dubey, Vikash Kumar
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (04) : 799 - 808
  • [5] Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
    Abel, Renata
    Ramos, Maria Paredes
    Chen, Qiaofeng
    Perez-Sanchez, Horacio
    Coluzzi, Flaminia
    Rocco, Monica
    Marchetti, Paolo
    Mura, Cameron
    Simmaco, Maurizio
    Bourne, Philip E.
    Preissner, Robert
    Banerjee, Priyanka
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [6] Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
    Son Tung Ngo
    Ngoc Quynh Anh Pham
    Ly Thi Le
    Duc-Hung Pham
    Vu, Van V.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (12) : 5771 - 5780
  • [7] A student led computational screening of peptide inhibitors against main protease of SARS-CoV-2
    Khan, Anika Tajrian
    Chowdhury, Golam Mahmud
    Hafsah, Juwairiyah
    Maruf, Md
    Raihan, Md Riyad Hossen
    Chowdhury, Md Talha
    Nawal, Nafisa
    Tasnim, Nishat
    Saha, Pranto
    Roy, Prottoy
    Tabassum, Raya
    Rodrigues, Souvick Patrick
    Hasan, Walid
    Samanta, Zarin Tasnim
    Kamal, Suprio
    Nazir, Md Shahoriar
    Ali, Md Ackas
    Halim, Mohammad A.
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2022, 50 (01) : 7 - 20
  • [8] Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
    Refaey, Rana H.
    El-Ashrey, Mohamed K.
    Nissan, Yassin M.
    VIROLOGY, 2021, 554 : 48 - 54
  • [9] Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2
    Fischer, Andre
    Sellner, Manuel
    Mitusinska, Karolina
    Bzowka, Maria
    Lill, Markus A.
    Gora, Artur
    Smiesko, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 17
  • [10] Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors
    Fiorucci, Diego
    Milletti, Eva
    Orofino, Francesco
    Brizzi, Antonella
    Mugnaini, Claudia
    Corelli, Federico
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (16): : 6242 - 6248